Mario Tiribelli

Mario Tiribelli

UNVERIFIED PROFILE

Are you Mario Tiribelli?   Register this Author

Register author
Mario Tiribelli

Mario Tiribelli

Publications by authors named "Mario Tiribelli"

Are you Mario Tiribelli?   Register this Author

100Publications

2670Reads

6Profile Views

The role of allogeneic stem-cell transplant in myelofibrosis in the era of JAK inhibitors: a case-based review.

Bone Marrow Transplant 2020 Apr 18;55(4):708-716. Epub 2019 Sep 18.

Section of Hematology, Department of Medicine, University of Verona, Verona, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41409-019-0683-1DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7113188PMC
April 2020

Splenectomy in Myelofibrosis: Indications, Efficacy, and Complications.

Clin Lymphoma Myeloma Leuk 2020 Apr 30. Epub 2020 Apr 30.

Department of Clinical Medicine and Surgery, University of Naples Federico II, Naples, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clml.2020.04.015DOI Listing
April 2020

"Variant-specific discrepancy when quantitating BCR-ABL1 e13a2 and e14a2 transcripts using the Europe Against Cancer qPCR assay." Is dPCR the key?

Eur J Haematol 2019 09 7;103(3):272-273. Epub 2019 Jul 7.

Unit of Blood Diseases and Stem Cell Transplantation, DPT of Clinical and Experimental Sciences, University of Brescia, ASST Spedali Civili di Brescia, Brescia, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/ejh.13282DOI Listing
September 2019

Does switching to a second-generation tyrosine kinase inhibitor or increasing imatinib dose have long-term benefits in chronic myeloid leukemia patients with suboptimal responses under upfront standard-dose of imatinib?

Leuk Res 2018 11 29;74:55-56. Epub 2018 Sep 29.

Division of Hematology and BMT, Department of Medical Area, University of Udine, Udine, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.leukres.2018.09.013DOI Listing
November 2018

The significance of early warning in chronic myeloid leukemia.

Expert Rev Hematol 2018 04 15;11(4):265-266. Epub 2017 Jun 15.

c Department of Medicine, Section of Hematology , University of Verona , Verona , Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/17474086.2017.1340715DOI Listing
April 2018

ABCG2 overexpression and deoxyadenosine analogue activity in acute myeloid leukemia.

Cancer 2017 12 20;123(24):4934-4935. Epub 2017 Oct 20.

Division of Hematology and Bone Marrow Transplantation Department of Medicine, University Hospital, Udine, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.31037DOI Listing
December 2017

ABCG2 and CD200 define patients at high risk of relapse in ELN favorable subgroup of AML.

Eur J Haematol 2017 Sep 20;99(3):269-274. Epub 2017 Jul 20.

Division of Hematology and Stem Cell Transplantation, Azienda Sanitaria Universitaria Integrata, Udine, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/ejh.12915DOI Listing
September 2017

High CD200 expression is associated with poor prognosis in cytogenetically normal acute myeloid leukemia, even in FlT3-ITD-/NPM1+ patients.

Leuk Res 2017 07 4;58:31-38. Epub 2017 Apr 4.

Division of Hematology and Bone Marrow Transplantation, Azienda Sanitaria Universitaria Integrata di Udine, Udine, Italy. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.leukres.2017.04.001DOI Listing
July 2017

Impact of fludarabine-based induction therapy on outcome of FLT3-/NPM1+ cytogenetically normal acute myeloid leukemia.

Am J Hematol 2017 Apr 13;92(4):E45-E47. Epub 2017 Feb 13.

Division of Hematology and BMT, Department of Experimental and Clinical Medical Sciences, Azienda Sanitaria Universitaria Integrata, Udine, Italy.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1002/ajh.24651
Publisher Site
http://dx.doi.org/10.1002/ajh.24651DOI Listing
April 2017

How could patient reported outcomes improve patient management in chronic myeloid leukemia?

Expert Rev Hematol 2017 Jan 30;10(1):9-14. Epub 2016 Nov 30.

a Division of Hematology and BMT, Department of Experimental and Clinical Medical Sciences , Azienda Sanitaria Universitaria Integrata di Udine , Udine , Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/17474086.2017.1262758DOI Listing
January 2017

ABCG2, Cytogenetics, and Age Predict Relapse after Allogeneic Stem Cell Transplantation for Acute Myeloid Leukemia in Complete Remission.

Biol Blood Marrow Transplant 2016 09 10;22(9):1621-1626. Epub 2016 May 10.

Division of Hematology and Stem Cell Transplantation, Azienda Ospedaliero-Universitaria di Udine, Udine, Italy.

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S10838791163006
Publisher Site
http://dx.doi.org/10.1016/j.bbmt.2016.05.002DOI Listing
September 2016

ABCG2 overexpression in patients with acute myeloid leukemia: Impact on stem cell transplantation outcome.

Am J Hematol 2015 Sep 22;90(9):784-9. Epub 2015 Jul 22.

Division of Hematology and Bone Marrow Transplantation, Azienda Ospedaliero-Universitaria di Udine, Udine, Italy.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1002/ajh.24084
Publisher Site
http://dx.doi.org/10.1002/ajh.24084DOI Listing
September 2015

Long-term efficacy and safety of nilotinib therapy after imatinib failure in eosinophilic myeloproliferative neoplasm and ETV6-ABL rearrangement.

Ann Hematol 2015 Aug 23;94(8):1423-4. Epub 2015 Apr 23.

Division of Hematology and Bone Marrow Transplantation, Azienda Ospedaliero-Universitaria di Udine, Udine, Italy,

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s00277-015-2381-4
Publisher Site
http://dx.doi.org/10.1007/s00277-015-2381-4DOI Listing
August 2015

Clinical factors predictive of myelofibrotic evolution in patients with polycythemia vera.

Ann Hematol 2015 May 20;94(5):873-4. Epub 2014 Nov 20.

Division of Hematology and BMT, Department of Experimental and Clinical Medical Sciences, Azienda Ospedialiero-Universitaria di Udine, P.le S. M. Misericordia, 15-33100, Udine, Italy,

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00277-014-2257-zDOI Listing
May 2015

Factors affecting outcome of allogeneic stem cell transplantation as salvage in patients with acute myeloid leukemia primary refractory to intensive induction therapy.

Am J Hematol 2014 Sep 19;89(9):933-4. Epub 2014 Jun 19.

Division of Hematology and Bone Marrow Transplantation, Department of Clinical and Experimental Medical Sciences, AOU Udine, Udine, Italy.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1002/ajh.23769
Publisher Site
http://dx.doi.org/10.1002/ajh.23769DOI Listing
September 2014

EUTOS score predicts early optimal response to imatinib according to the revised 2013 ELN recommendations.

Ann Hematol 2014 Jan 29;93(1):163-4. Epub 2013 Nov 29.

Department of Medicine, Section of Hematology, University of Verona, Verona, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00277-013-1974-zDOI Listing
January 2014

EUTOS score predicts long-term outcome but not optimal response to imatinib in patients with chronic myeloid leukaemia.

Leuk Res 2013 Nov 11;37(11):1457-60. Epub 2013 Aug 11.

Division of Hematology and Bone Marrow Transplantation, Azienda Ospedaliero - Universitaria di Udine, Italy. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.leukres.2013.07.037DOI Listing
November 2013

BAALC overexpression retains its negative prognostic role across all cytogenetic risk groups in acute myeloid leukemia patients.

Am J Hematol 2013 Oct 23;88(10):848-52. Epub 2013 Jul 23.

Division of Hematology and Bone Marrow Transplantation, Azienda Ospedaliero-Universitaria Udine, Udine, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ajh.23516DOI Listing
October 2013

Donor compatibility and performance status affect outcome of allogeneic haematopoietic stem cell transplant in patients with relapsed or refractory acute myeloid leukaemia.

Ann Hematol 2012 Dec 15;91(12):1937-43. Epub 2012 Aug 15.

Division of Hematology and Bone Marrow Transplantation & Department of Experimental and Clinical Medical Sciences, Azienda Ospedaliero-Universitaria di Udine, P.zzale S. M. Misericordia, 15, 33100 Udine, Italy.

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s00277-012-1551-x
Publisher Site
http://dx.doi.org/10.1007/s00277-012-1551-xDOI Listing
December 2012

Tyrosine kinase inhibitors for elderly chronic myeloid leukemia patients: a systematic review of efficacy and safety data.

Crit Rev Oncol Hematol 2012 Oct 27;84(1):93-100. Epub 2012 Jan 27.

Department of Cellular Biotechnologies and Hematology, Sapienza University, Rome, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.critrevonc.2012.01.001DOI Listing
October 2012

Histone post-translational modifications associated to BAALC expression in leukemic cells.

Biochem Biophys Res Commun 2012 Jan 14;417(2):721-5. Epub 2011 Dec 14.

Istituto di Genetica Medica, Azienda Ospedaliero-Universitaria S. Maria della Misericordia Udine, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbrc.2011.12.013DOI Listing
January 2012

Nutlin-3 downregulates the expression of the oncogene TCL1 in primary B chronic lymphocytic leukemic cells.

Clin Cancer Res 2011 Sep 13;17(17):5649-55. Epub 2011 Jul 13.

Department of Morphology and Embryology and LTTA Centre, University of Ferrara, Ferrara, Italy.

View Article

Download full-text PDF

Source
http://clincancerres.aacrjournals.org/cgi/doi/10.1158/1078-0
Publisher Site
http://dx.doi.org/10.1158/1078-0432.CCR-11-1064DOI Listing
September 2011

[Time trend in cancer incidence among 0-24 year-old residents of the Province of Trieste, Italy, 1972-2003].

Epidemiol Prev 2009 Jul-Oct;33(4-5):161-8

Unità clinica operativa di anatomia patologica, Ospedale di Cattinara, Strada di Fiume 447, Trieste.

View Article

Download full-text PDF

Source
May 2011

Concomitant ABCG2 overexpression and FLT3-ITD mutation identify a subset of acute myeloid leukemia patients at high risk of relapse.

Cancer 2011 May 29;117(10):2156-62. Epub 2010 Nov 29.

Division of Hematology and Bone Marrow Transplantation, Department of Medical and Morphological Researches, AOU Udine, Udine, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.25753DOI Listing
May 2011

Cardiotoxicity of imatinib: At the heart of the problem.

Leuk Res 2011 Jan;35(1):36-7

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.leukres.2010.09.021DOI Listing
January 2011

Two novel NPM1 mutations in a therapy-responder AML patient.

Hematol Oncol 2010 Sep;28(3):151-5

Dipartimento di Scienze e Tecnologie Biomediche, Facoltà di Medicina, Università di Udine, Udine, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/hon.906DOI Listing
September 2010

Fludarabine-based induction therapy does not overcome the negative effect of ABCG2 (BCRP) over-expression in adult acute myeloid leukemia patients.

Leuk Res 2010 Jul 31;34(7):942-5. Epub 2010 Jan 31.

Clinica Ematologica e Centro Trapianti e Terapie Cellulari C. Melzi, Azienda Ospedaliero-Universitaria di Udine, Dipartimento di Ricerche Mediche e Morfologiche, Università di Udine, Udine, Italy.

View Article

Download full-text PDF

Source
http://linkinghub.elsevier.com/retrieve/pii/S014521261000009
Publisher Site
http://dx.doi.org/10.1016/j.leukres.2010.01.008DOI Listing
July 2010

The oncogene DEK promotes leukemic cell survival and is downregulated by both Nutlin-3 and chlorambucil in B-chronic lymphocytic leukemic cells.

Clin Cancer Res 2010 Mar 9;16(6):1824-33. Epub 2010 Mar 9.

Department of Morphology and Embryology, University of Ferrara, Ferrara, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-09-3031DOI Listing
March 2010

Nilotinib and donor lymphocyte infusion in the treatment of Philadelphia-positive acute lymphoblastic leukemia (Ph+ ALL) relapsing after allogeneic stem cell transplantation and resistant to imatinib.

Leuk Res 2009 Jan 8;33(1):174-7. Epub 2008 May 8.

Division of Hematology and Bone Marrow Transplantation, Department of Medical and Morphological Researches, Azienda Ospedaliero-Universitaria, P.zzale S. M. Misericordia, 15, 33100 Udine, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.leukres.2008.03.031DOI Listing
January 2009

Gemtuzumab-ozogamicin in combination with fludarabine, cytarabine, idarubicin (FLAI-GO) as induction therapy in CD33-positive AML patients younger than 65 years.

Leuk Res 2008 Dec 14;32(12):1800-8. Epub 2008 Jul 14.

Division of Hematology, Bone Marrow Transplantation Unit, Department of Clinical and Morphological Research, University Hospital, Udine, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.leukres.2008.05.011DOI Listing
December 2008

Combined treatment of CpG-oligodeoxynucleotide with Nutlin-3 induces strong immune stimulation coupled to cytotoxicity in B-chronic lymphocytic leukemic (B-CLL) cells.

J Leukoc Biol 2008 Feb 12;83(2):434-7. Epub 2007 Nov 12.

Department of Morphology and Embryology, University of Ferrara, Via Fossato di Mortara 66, 44100 Ferrara, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1189/jlb.0707459DOI Listing
February 2008

Differential gene expression induction by TRAIL in B chronic lymphocytic leukemia (B-CLL) cells showing high versus low levels of Zap-70.

J Cell Physiol 2007 Oct;213(1):229-36

Department of Morphology and Embryology, Human Anatomy Section, University of Ferrara, Ferrara, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/jcp.21116DOI Listing
October 2007

Synergistic cytotoxic activity of recombinant TRAIL plus the non-genotoxic activator of the p53 pathway nutlin-3 in acute myeloid leukemia cells.

Curr Drug Metab 2007 May;8(4):395-403

Department of Morphology and Embryology, Human Anatomy Section, University of Ferrara, Via Fossato di Mortara 66, 44100 Ferrara, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2174/138920007780655432DOI Listing
May 2007